What Researchers Did
Researchers reviewed 30 peer-reviewed clinical trials involving over 4,400 patients to investigate the relationship between glycosylated hemoglobin (HbA1c) levels and diabetic foot ulcer healing.
What They Found
The average HbA1c was 8.6% in intervention groups and 8.3% in control groups across the studies. Twenty-five out of 30 trials showed no direct correlation between HbA1c levels and wound healing, and no randomized controlled trial data demonstrated that HbA1c below 7.0% improves diabetic wound healing. Wounds healed even with high HbA1c levels that would be considered poorly controlled.
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers should not face denial of hyperbaric oxygen therapy based solely on an HbA1c level above 7.0%. Treatment decisions for limb-threatening diabetic foot ulcers should consider a broader clinical picture rather than a single HbA1c threshold.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's conclusions are limited by its reliance on the quality and reporting of previously published primary research.